Insider · CIK 0001578251

Walsh Jeffrey T.

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001578251

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-28	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+120K sh	—	—	120,000
2025-05-29	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+107K sh	—	—	107,400
2024-10-18	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+34K sh	—	—	34,000
2023-06-09	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+29.5K sh	—	—	29,532
2022-06-10	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+39.7K sh	—	—	39,727
2019-08-20	bluebird bio, Inc.M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	+500 sh	$24.47	+$12.2K	41,421
2019-08-20	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−500 sh	$124.00	−$62K	40,921
2019-08-20	bluebird bio, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	−500 sh	—	—	9,521
2019-06-18	bluebird bio, Inc.M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	+100 sh	$24.47	+$2,447	41,021
2019-06-18	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−100 sh	$126.12	−$12.6K	40,921
2019-06-18	bluebird bio, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	−100 sh	—	—	10,021
2019-06-10	bluebird bio, Inc.M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	+1,400 sh	$24.47	+$34.3K	42,321
2019-06-10	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−1,200 sh	$125.19	−$150K	41,121
2019-06-10	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−200 sh	$126.96	−$25.4K	40,921
2019-06-10	bluebird bio, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	−1,400 sh	—	—	10,121
2019-05-10	bluebird bio, Inc.M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	+1,500 sh	$24.47	+$36.7K	42,421
2019-05-10	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−200 sh	$131.10	−$26.2K	42,221
2019-05-10	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−1,100 sh	$132.38	−$146K	41,121
2019-05-10	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−200 sh	$133.08	−$26.6K	40,921
2019-05-10	bluebird bio, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	−1,500 sh	—	—	11,521
2019-04-10	bluebird bio, Inc.M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	+1,500 sh	$24.47	+$36.7K	42,421
2019-04-10	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−1,100 sh	$156.44	−$172K	41,321
2019-04-10	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−400 sh	$157.23	−$62.9K	40,921
2019-04-10	bluebird bio, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	−1,500 sh	—	—	13,021
2019-03-11	bluebird bio, Inc.M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	+1,500 sh	$24.47	+$36.7K	42,421
2019-03-11	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−1,500 sh	$139.80	−$210K	40,921
2019-03-11	bluebird bio, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	−1,500 sh	—	—	14,521
2019-02-08	bluebird bio, Inc.M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	+1,500 sh	$24.47	+$36.7K	42,421
2019-02-08	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−1,000 sh	$130.99	−$131K	41,421
2019-02-08	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−500 sh	$131.87	−$65.9K	40,921
2019-02-08	bluebird bio, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Strategy Officer	DDisposition to Issuer	−1,500 sh	—	—	16,021
2019-02-01	bluebird bio, Inc.A Award	Chief Strategy Officer	AAward	+8,438 sh	—	—	40,921
2019-02-01	bluebird bio, Inc.Stock Option (right to buy)A Award	Chief Strategy Officer	AAward	+33.8K sh	—	—	33,750
2019-01-16	bluebird bio, Inc.M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	+3,000 sh	$24.47	+$73.4K	35,483
2019-01-16	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−3,000 sh	$125.14	−$375K	32,483
2019-01-16	bluebird bio, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	−3,000 sh	—	—	17,521
2019-01-07	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−1,979 sh	$113.29	−$224K	33,516
2019-01-07	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−1,033 sh	$114.31	−$118K	32,483
2018-11-09	bluebird bio, Inc.M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	+1,500 sh	$24.47	+$36.7K	36,995
2018-11-09	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−320 sh	$129.12	−$41.3K	36,675
2018-11-09	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−700 sh	$130.61	−$91.4K	35,975
2018-11-09	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−480 sh	$131.55	−$63.1K	35,495
2018-11-09	bluebird bio, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	−1,500 sh	—	—	20,521
2018-10-10	bluebird bio, Inc.M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	+1,500 sh	$24.47	+$36.7K	36,995
2018-10-10	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−1,100 sh	$134.95	−$148K	35,895
2018-10-10	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−300 sh	$135.70	−$40.7K	35,595
2018-10-10	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−100 sh	$136.83	−$13.7K	35,495
2018-10-10	bluebird bio, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	−1,500 sh	—	—	22,021
2018-09-10	bluebird bio, Inc.M Exercise/Conversion	Chief Strategy Officer	MExercise/Conversion	+1,500 sh	$24.47	+$36.7K	36,995
2018-09-10	bluebird bio, Inc.S Sale	Chief Strategy Officer	SSale	−501 sh	$149.22	−$74.8K	36,494

Recent filings

Accepted (ET)
May 294
Walsh Jeffrey T.0001193125-26-249132
SEC(opens sec.gov)
May 304
Walsh Jeffrey T.0000950170-25-079949
SEC(opens sec.gov)
Oct 214
Walsh Jeffrey T.0000950170-24-116065
SEC(opens sec.gov)
Jun 124
Walsh Jeffrey T.0001209191-23-036527
SEC(opens sec.gov)
Jun 134
Walsh Jeffrey T.0001209191-22-036543
SEC(opens sec.gov)
Aug 214
Walsh Jeffrey T.0001209191-19-046968
SEC(opens sec.gov)
Jun 204
Walsh Jeffrey T.0001209191-19-038250
SEC(opens sec.gov)
Jun 124
Walsh Jeffrey T.0001209191-19-036381
SEC(opens sec.gov)
May 144
Walsh Jeffrey T.0001209191-19-029597
SEC(opens sec.gov)

Companies

Address

C/O TENAYA THERAPEUTICS, INC. 171 OYSTER POINT BLVD., 5TH FLOOR

SOUTH SAN FRANCISCO, CA, 94080